Interfering with lysophosphatidic acid receptor edg2/lpa1 signalling slows down disease progression in SOD1‐G93A transgenic mice.

Autor: Gento‐Caro, Ángela1,2 (AUTHOR), Vilches‐Herrando, Esther1,2 (AUTHOR), García‐Morales, Victoria1,2 (AUTHOR), Portillo, Federico1,2 (AUTHOR), Rodríguez‐Bey, Guillermo1,3 (AUTHOR), González‐Forero, David1,2 (AUTHOR) david.gonzalezforero@uca.es, Moreno‐López, Bernardo1,2 (AUTHOR) bernardo.moreno@uca.es
Zdroj: Neuropathology & Applied Neurobiology. Dec2021, Vol. 47 Issue 7, p1004-1018. 15p.
Databáze: Academic Search Ultimate